Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

24.86 +1.21 (+5.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
99 100 Next >
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
Wall Street began Tuesday’s session on a weaker note, with major indices slipping after November's robust retail sales report reignited investor concerns that the Federal Reserve might hold back... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry
Super Micro Computer's stock is trading below its 50-day moving average ahead of its removal from the Nasdaq 100 Index on Dec. 23, 2024. The company faces delisting concerns and is seeking to raise... 
Via Benzinga
Nasdaq 100 Shakeup: 3 Stocks That Can Gain
Three stocks have their price targets above current price levels. 
Via Talk Markets
Topics Stocks / Equities
What's Going On Moderna Stock On Monday?
Moderna faces index removal, stock plunge, vaccine challenges, and lawsuits, while focusing on R&D in oncology and rare diseases for future growth. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Unpacking the Latest Options Trading Trends in Moderna
Via Benzinga
Expert Outlook: Moderna Through The Eyes Of 19 Analysts
Via Benzinga
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
Via Benzinga
What's Going On With Super Micro Computer Shares Monday?
Super Micro is expected to be removed from the Nasdaq 100 Index later this month. 
Via Benzinga
US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'
U.S. stock futures were trading higher after the Nasdaq 100 extended its relentless climb last week, nearing the 22,000-point milestone. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Why I Can't Stop Buying This Ultra-High-Yielding ETF
Via The Motley Fool
Palantir Stock Is Joining the Nasdaq-100 Index, and Super Micro Computer Is Being Booted: What Investors Should Know
Palantir stock's huge rise this year has earned it a spot on another stock index. 
Via The Motley Fool
Moderna to Present at Upcoming Conferences in December 2024
Via ACCESSWIRE
Looking Into Moderna's Recent Short Interest
Via Benzinga
Unpacking the Latest Options Trading Trends in Moderna
Via Benzinga
MicroStrategy, Palantir, Axon Added To Nasdaq 100: Super Micro Computer, Moderna, Illumina Exit The Index
The much-awaited reconstitution of the Nasdaq 100 index has taken place, resulting in the addition of Bitcoin (CRYPTO: BTC) proxy MicroStrategy Inc. (NASDAQ:MSTR), Palantir Technologies Inc. (NASDAQ: 
Via Benzinga
Bird Flu Spreads To Cats, Possibly Horses As Officials Signal No Plans To Authorize Vaccination
Avian flu continues to spread with cases in cats, horses, and humans. Scientists monitor wildlife infections. Vaccine development may face challenges. 
Via Benzinga
Palantir, MicroStrategy Likely To Join Nasdaq 100; Will Moderna, Super Micro Get The Axe?
Will Moderna, Super Micro get the axe in the annual rebalancing? 
Via Investor's Business Daily
These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over
Via The Motley Fool
Topics Stocks
Exposures US Equities
Super Micro Computer Teeters On Edge Of Nasdaq 100: Can xAI, Nvidia Help Stabilize Trajectory?
Super Micro faces potential delisting from Nasdaq 100 Index due to underperformance and auditing scandal. Uncertainty surrounds its future. 
Via Benzinga
Large-Cap Stocks In Trouble - Sunday, Dec. 8
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Topics Stocks / Equities
Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Top performers last week: RIVN, RKLB, SRPT, EXAS, ESTC, ULTA, MRNA, RL, CPRT, SNAP. Any in your portfolio? Citigroup raises price target on ULTA and SNAP. 
Via Benzinga
10 Worst Performing Large-Caps Last 12 Months
Over the past twelve months ten Large-Cap stocks have underperformed all others. 
Via Talk Markets
Topics Stocks / Equities
Bird Flu Found In Raw Milk Leads To Recall In California
Bird flu has been detected in a batch of raw milk sold in California and a voluntary recall of the milk has been issued at the request of the state's department of public health. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
Via The Motley Fool
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
Via Benzinga
Large-Cap Stocks In Trouble - Saturday, Nov. 23
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Topics Stocks / Equities
Is Biotech’s Bull Run Over? Examining Election Impacts
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. 
Via MarketBeat
Topics ETFs Government
Exposures Political
Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?
According to the Los Angeles Times, the total bird flue case count in the U.S. stands at 54; 31 cases are attributed to the dairy industry. 
Via Benzinga
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
Moderna plans to prioritize new product approvals and oncology investments, as political concerns over Robert F. Kennedy Jr.'s HHS nomination weigh on vaccine stocks. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback